Sanders Mulls Generic Possibilities As He Blasts Novo Over High Ozempic And Wegovy Prices
Suggests Generics Could Sell For $100 A Month; Novo CEO Open To Potential Talks With PBMs
In a closely anticipated US Senate Committee hearing, Novo’s CEO was grilled by US senator Bernie Sanders and others on the high price of Ozempic and Wegovy in the country.
